Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer
| Autor: | Schmidt, M. †, Rüttinger, D. †, Sebastian, M., Hanusch, C.A., Marschner, N., Baeuerle, P.A., Wolf, A., Göppel, G., Oruzio, D., Schlimok, G., Steger, G.G., Wolf, C., Eiermann, W., Lang, A., Schuler, M. * |
|---|---|
| Zdroj: | In Annals of Oncology September 2012 23(9):2306-2313 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|